Methods and systems for presenting a combination treatment

• US 20090319301A1
• Filed: 12/01/2008
• Published: 12/24/2009
• Est. Priority Date: 04/24/2008
• Status: Active Grant

• Current Assignee: Harvest Bio LLC
• Original Assignee: Searete LLC A Limited Liability Corporation of The State of Delaware
• Inventors: Ishikawa, Muriel Y., Lord, Robert W., Levien, Royce A., Wood, Lowell L. JR., Hyde, Roderick A., Malamud, Mark A., Sweeney, Elizabeth A., Wood, Victoria Y.H., Leuthardt, Eric C.
• Granted Patent: US 9,649,469 B2
• Time in Patent Office: Days
• US Class Current: 705/3
• CPC Class Codes: A61M 2021/005 images, e.g. video
• CPC Class Codes: A61M 2021/0077 with application of chemical or pharmacological stimulus
• CPC Class Codes: A61M 21/02 for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia for massage A61H; electrotherapy A61N, e.g. applying alternating or intermittent electric currents for producing anaesthesia A61N1/36021
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 20/70 relating to mental therapies, e.g. psychological therapy or autogenous training

Abstract

Methods, computer program products, and systems are described that include accepting an indication of a schedule for administration of a bioactive agent to an individual and presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual.

Claims

1-94. -94. (canceled)

95. A system, comprising:

an accepter module; and

a presenter module configured to present an indication of an artificial sensory experience at least partly based on accepting an indication of a schedule for administration of a bioactive agent to an individual.

96. The system of claim 95, wherein the accepter module comprises:

a time schedule accepter module.

97. The system of claim 95, wherein the accepter module comprises:

a bioactive agent schedule accepter module.

98. The system of claim 95, wherein the accepter module comprises:

a dose accepter module.

99. The system of claim 95, wherein the presenter module configured to present an indication of an artificial sensory experience at least partly based on accepting an indication of a schedule for administration of a bioactive agent to an individual comprises:

a prescription presenter module.

100. The system of claim 99, wherein the prescription presenter module comprises:

an effect presenter module.

101. The system of claim 100, wherein the effect presenter module comprises:

a desired effect presenter module.

102. The system of claim 100, wherein the effect presenter module comprises:

an adverse effect presenter module.

103. The system of claim 99, wherein the prescription presenter module comprises:

an effectiveness presenter module.

104. The system of claim 99, wherein the prescription presenter module comprises:

a concentration presenter module.

105. The system of claim 99, wherein the prescription presenter module comprises:

a recommender module.

106. The system of claim 95, wherein the presenter module configured to present an indication of an artificial sensory experience at least partly based on accepting an indication of a schedule for administration of a bioactive agent to an individual comprises:

an algorithm utilizer module.

107. The system of claim 106, wherein the algorithm utilizer module comprises:

a pharmacokinetic software utilizer module.

108. The system of claim 106, wherein the algorithm utilizer module comprises:

a pharmacodynamic software utilizer module.

109. The system of claim 106, wherein the algorithm utilizer module comprises:

a contraindication algorithm utilizer module.

110. The system of claim 95, wherein the presenter module configured to present an indication of an artificial sensory experience at least partly based on accepting an indication of a schedule for administration of a bioactive agent to an individual comprises:

a medical history presenter module.

111. The system of claim 95, wherein the presenter module configured to present an indication of an artificial sensory experience at least partly based on accepting an indication of a schedule for administration of a bioactive agent to an individual comprises:

an experimental data presenter module.

112. The system of claim 95, wherein the presenter module configured to present an indication of an artificial sensory experience at least partly based on accepting an indication of a schedule for administration of a bioactive agent to an individual comprises:

a medical reference tool presenter module.

113. The system of claim 95, wherein the presenter module configured to present an indication of an artificial sensory experience at least partly based on accepting an indication of a schedule for administration of a bioactive agent to an individual comprises:

an output device presenter module.

114. The system of claim 113, wherein the output device presenter module comprises:

an user interface presenter module.

115. The system of claim 113, wherein the output device presenter module comprises:

a mobile device presenter module.

116. The system of claim 95, wherein the presenter module configured to present an indication of an artificial sensory experience at least partly based on accepting an indication of a schedule for administration of a bioactive agent to an individual comprises:

a third party presenter module.

117. The system of claim 116, wherein the third party presenter module comprises:

a health care provider presenter module.

118. The system of claim 116, wherein the third party presenter module comprises:

a selective presenter module.

119. The system of claim 95, further comprising:

a profile accepter module.

120. The system of claim 119, wherein the profile accepter module comprises:

a concentration representation accepter module.

121. The system of claim 119, wherein the profile accepter module comprises:

a response representation accepter module.

122. The system of claim 119, wherein the profile accepter module comprises:

a plasma concentration accepter module.

123. The system of claim 119, wherein the profile accepter module comprises:

a bioavailability profile accepter module.

124. The system of claim 119, wherein the profile accepter module comprises:

a model accepter module.

125. The system of claim 124, wherein the model accepter module comprises:

a physiological model accepter module.

126. The system of claim 124, wherein the model accepter module comprises:

an in vitro model accepter module.

127. The system of claim 124, wherein the model accepter module comprises:

a software output accepter module.

128. The system of claim 119, wherein the profile accepter module comprises:

a characteristic accepter module.

129. The system of claim 119, wherein the profile accepter module comprises:

an attribute profile accepter module.

130. The system of claim 129, wherein the attribute profile accepter module comprises:

a physiological characteristic accepter module.

131. The system of claim 129, wherein the attribute profile accepter module comprises:

a medical history profile accepter module.

132. The system of claim 129, wherein the attribute profile accepter module comprises:

a group attribute accepter module.

133. The system of claim 119, wherein the profile accepter module comprises:

a parameter accepter module.

134. The system of claim 95, further comprising:

a determiner module.